Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirusAnna Kanerva, Akseli Hemminki, Gerd Bauerschmitz et al.|Molecular Therapy|2003Cited by 172
Noninvasive Bioluminescence Imaging in Small AnimalsKurt R. Zinn, Stuart J. Frank, April Szafran et al.|ILAR Journal|2008Cited by 150
Noninvasive monitoring of gene transfer using a reporter receptor imaged with a high-affinity peptide radiolabeled with 99mTc or 188Re.Kurt R. Zinn, Buck E. Rogers, James M. Mountz et al.|PubMed|2000Cited by 144
An Adenovirus with Enhanced Infectivity Mediates Molecular Chemotherapy of Ovarian Cancer Cells and Allows Imaging of Gene ExpressionAkseli Hemminki, Ronald D. Alvarez, Donald J. Buchsbaum et al.|Molecular Therapy|2001Cited by 127
FcγRs Modulate Cytotoxicity of Anti-Fas Antibodies: Implications for Agonistic Antibody-Based TherapeuticsYuanyuan Xu, Robert P. Kimberly, Alexander J. Szalai et al.|The Journal of Immunology|2003Cited by 106